News | March 12, 2024
AstraZeneca Pharma India, Mankind Pharma ink pact to distribute asthma medicine
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
‘Unmask Anemia’ aims to simplify assessment of iron deficiency anemia risk with an easy online self-test based on common signs and symptoms
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
The CDCCs are strategically positioned in regions identified as high-impact areas
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Innovent will supply sintilimab for the collaborated clinical trial
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
